Viracta Therapeutics, Inc.
VIRXDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001061027
Viracta Therapeutics, Inc. was delisted in 2025; its insiders filed their last Form 4 on Nov 27, 2024; 32 institutions reported holding it in 13F filings for Q4 2024, worth $583.0K in total; no superinvestor held it.
13F holders, Q4 2024
Institutional positions in Viracta Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
VIRX is no longer listed, so this page shows Q4 2024. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 32
- −5 vs. Q3 2024
- Shares held
- 3.62M
- −1.96M (−35.2%) vs. Q3 2024
- Total value
- $583.0K
- −$707.1K (−54.8%) vs. Q3 2024
- New holders
- 6
- 5 more added
- Sold out
- 11
- 4 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 7 | $3.80K |
| Q4 2024 | 32 | $583.0K |
| Q3 2024 | 38 | $1.29M |
| Q2 2024 | 40 | $4.91M |
| Q1 2024 | 40 | $9.82M |
| Q4 2023 | 42 | $5.61M |
| Q3 2023 | 42 | $10.1M |
| Q2 2023 | 41 | $14.1M |
| Q1 2023 | 48 | $19.5M |
| Q4 2022 | 56 | $18.1M |
| Q3 2022 | 59 | $52.8M |
| Q2 2022 | 63 | $44.2M |
| Q1 2022 | 69 | $62.4M |
| Q4 2021 | 69 | $65.4M |
| Q3 2021 | 68 | $124.6M |
| Q2 2021 | 63 | $151.8M |
| Q1 2021 | 50 | $92.0M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Viracta Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 1,626,258 | $261.7K | 0.00% | +106,018+7.0% | Added |
| Vanguard Group Inc | 289,174 | $46.6K | 0.00% | −665,311−69.7% | Reduced |
| Aisling Capital Management LP | 288,571 | $46.2K | 0.02% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 286,395 | $46.1K | 0.00% | +40,996+16.7% | Added |
| BlackRock, Inc. | 234,846 | $37.8K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 224,250 | $36.1K | 0.00% | −25,757−10.3% | Reduced |
| Virtu Financial LLC | 128,231 | $21.0K | 0.00% | +128,231 | New |
| UBS Group AG | 93,177 | $15.0K | 0.00% | +93,082+97,981.1% | Added |
| HRT Financial LP | 82,673 | $13.0K | 0.00% | −56,149−40.4% | Reduced |
| State Street Corp | 65,867 | $10.6K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 55,422 | $8.92K | 0.00% | +55,422 | New |
| United Capital Financial Advisers, LLC | 42,995 | $6.88K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 38,104 | $6.13K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 36,135 | $5.81K | 0.00% | +5,466+17.8% | Added |
| Inspirion Wealth Advisors, LLC | 25,000 | $5.28K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 16,491 | $2.65K | 0.00% | +16,491 | New |
| WealthTrust Axiom LLC | 16,396 | $2.64K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 14,809 | $2.38K | 0.00% | +4,635+45.6% | Added |
| Colony Group, LLC | 14,000 | $2.25K | 0.00% | 00.0% | Unchanged |
| Trust Co of Toledo NA | 12,317 | $1.98K | 0.00% | 00.0% | Unchanged |
| Baader Bank INC | 10,826 | $1.56K | 0.00% | +10,826 | New |
| RP Management, LLC | 3,700 | $851 | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 4,018 | $647 | 0.00% | +4,018 | New |
| IAG Wealth Partners, LLC | 3,000 | $483 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,124 | $180 | 0.00% | −13,930−92.5% | Reduced |
| Oarsman Capital, Inc. | 1,000 | $161 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 721 | $116 | 0.00% | 00.0% | Unchanged |
| Indiana Trust & Investment Management CO | 200 | $32 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 180 | $29 | 0.00% | +180 | New |
| Wells Fargo & Company | 171 | $28 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 8 | $1 | 0.00% | 00.0% | Unchanged |
| Addison Advisors LLC | 4 | $1 | 0.00% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 0 | $0 | 0.00% | −689,709−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −332,189−100.0% | Sold out |
| Landscape Capital Management, L.L.C. | 0 | $0 | 0.00% | −68,317−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −27,090−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −13,870−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −10,908−100.0% | Sold out |
| Dunhill Financial, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Planned Solutions, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Planning Capital Management Corp | – | – | – | – | Not filed |